November is pancreatic cancer awareness month as survivors and advocates highlight the disease. It accounts for 3 percent of all cancer diagnoses in the U.S. and at least 7 percent of all cancer ...

In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of ...

A new case report was published in Volume 13 of Oncoscienceon February 7, 2026, titled "Massive calcified solid ...

In recent years, AI has infiltrated hospitals: We now have everything from digital nursing assistants to robotic surgeries. For their next feat, computers are taking on cancer detection. Scientists ...

In the month since oncologists at New Hyde Park, N.Y.-based Northwell Health began using iNav — an artificial intelligence-enabled diagnostic tool developed in-house — people with pancreatic cancer ...

Dr. Jon S. DuBois: A 29-year-old woman was evaluated in the gastroenterology clinic of this hospital for the management of a soft-tissue mass in the head of the pancreas. The patient had been well ...

“This case underscores the importance of obtaining tissue diagnosis in the setting of a pancreatic mass before embarking on definitive treatment.” In this report led by first author Osama Mohiuddin ...

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

Please provide your email address to receive an email when new articles are posted on . Malats and colleagues analyzed stool and saliva samples from a Spanish case-control study that included 57 newly ...